Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Exercise/Conversion of 3,500 ORKA shares, $23.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Sep 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Aug 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Jul 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Jun 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| May 16, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Apr 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Mar 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Feb 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 3,500 | $23.9K |
| Jan 23, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 32,500 | n/a |